CaMKI (Calcium/Calmodulin-dependent protein kinase I) inhibitors represent a class of chemical compounds designed to specifically target and modulate the activity of CaMKI, a serine/threonine kinase enzyme. CaMKI is a key player in intracellular signaling pathways and is particularly important in regulating various cellular processes, including neuronal plasticity, gene expression, and cell cycle progression. Its activity is tightly regulated by calcium and calmodulin, which bind to CaMKI and activate it, leading to phosphorylation of downstream target proteins. CaMKI inhibitors, therefore, function by interfering with this activation process, ultimately downregulating CaMKI-mediated signaling cascades.
The structural diversity of CaMKI inhibitors is vast, encompassing small organic molecules, peptides, and synthetic compounds. These inhibitors typically work by competing with calmodulin for binding to CaMKI's catalytic domain or by directly targeting the kinase's active site, thereby preventing its phosphorylation activity. Through these mechanisms, CaMKI inhibitors serve as valuable tools in basic research, enabling scientists to dissect the roles of CaMKI in various cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 inhibits CaMKII by preventing the binding of calmodulin and Ca2+ to CaMKII, thus blocking its activation. | ||||||
KN-62 | 127191-97-3 | sc-3560 | 1 mg | $136.00 | 20 | |
KN-62 is a CaMKII inhibitor that competes with ATP for binding to the kinase domain, interfering with its activity. | ||||||
KN-92 | 1135280-28-2 | sc-311369 sc-311369A | 1 mg 5 mg | $186.00 $572.00 | 7 | |
KN-92 inhibits CaMKII by binding to the calmodulin-binding domain, preventing its interaction with calmodulin. | ||||||
1-Naphthyl PP1 | 221243-82-9 | sc-203765 sc-203765A | 10 mg 50 mg | $235.00 $983.00 | 3 | |
1-Naphthyl PP1 is a selective CaMKII inhibitor that targets the kinase domain, blocking its phosphorylation activity. | ||||||
Cdk9 Inhibitor II | 140651-18-9 | sc-203326 | 5 mg | $172.00 | 1 | |
CK59 inhibits CaMKII by binding to its ATP-binding site, interfering with the kinase's ability to phosphorylate substrates. | ||||||
STO-609 | 52029-86-4 | sc-507444 | 5 mg | $140.00 | ||
STO-609 inhibits CaMKK, a kinase that activates CaMKII, by interfering with its ATP-binding site. | ||||||